[Diazoxide: mechanism of its hyperglycemic action and therapeutic possibilities].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000818:Animals; D002395:Catecholamines / Q000378:metabolism; D003981:Diazoxide / Q000008:administration & dosage / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use; D004357:Drug Synergism; D004789:Enzyme Activation; D005951:Glucose Tolerance Test; D005964:Glucosyltransferases / Q000378:metabolism; D006008:Glycogen Storage Disease / Q000188:drug therapy; D007003:Hypoglycemia / Q000188:drug therapy*; D066298:In Vitro Techniques; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D008854:Microscopy, Electron; D010179:Pancreas / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D051381:Rats; D013566:Sympathomimetics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D002395:Catecholamines; D004232:Diuretics; D007328:Insulin; D013566:Sympathomimetics; D014665:Vasodilator Agents; D005964:Glucosyltransferases; D003981:Diazoxide